ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Authors
Category Primary study
JournalBLOOD
Year 2024
This article has no abstract
Epistemonikos ID: cc75dce7a75fa14d28fbada15aa75ca9fa7fe146
First added on: Jul 18, 2025